Skip to main navigation Skip to search Skip to main content

Correction to: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (Nature Medicine, (2025), 31, 8, (2806-2814), 10.1038/s41591-025-03738-z)

  • Neal D. Shore
  • , Thomas B. Powles
  • , Jens Bedke
  • , Matthew D. Galsky
  • , Joan Palou Redorta
  • , Ja Hyeon Ku
  • , Michal Kretkowski
  • , Evanguelos Xylinas
  • , Boris Alekseev
  • , Dingwei Ye
  • , Félix Guerrero-Ramos
  • , Alberto Briganti
  • , Girish S. Kulkarni
  • , Julia Brinkmann
  • , Anna Maria Calella
  • , Rossano Cesari
  • , Anthony Eccleston
  • , Elisabete Michelon
  • , Jennifer Vermette
  • , Caimiao Wei
    • Gary D. Steinberg

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (Nature Medicine, (2025), 31, 8, (2806-2814), 10.1038/s41591-025-03738-z)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases